Keywords: Tumors (Pre-Treatment), Cancer
Motivation: IDH-mutant gliomas are associated with a favorable prognosis; however, the unique metabolic and cellular adaptations distinguishing IDH-mutant from IDH-wild-type gliomas are not yet comprehensively unraveled.
Goal(s): Investigate and quantify the metabolic pool and kinetics in IDH-mutant and wild-type gliomas using intracellular metabolite-profiling and Consumption and Release (CORE) dynamic measurements.
Approach: Metabolic pool and CORE dynamics were investigated using 1H-NMR (700 MHz), quantifying LN229 intracellular-metabolites together with CORE-measurements using metabolite estimations from Fresh-and-Spent media.
Results: IDH mutants showed higher Ki-67 and proliferation rate, significantly elevated intracellular-glutamine and glucose concentrations accompanied-with enhanced consumption of glutamine and glucose, and disrupted Pyruvate utilization in Anaplerotic and TCA-pathways.
Impact: 1H-NMR-based investigations and transcriptomic-profiling suggests that IDH-mutant gliomas undergo unique metabolic-adaptations, showing increased glutamine-glutamate dependency, disrupted pyruvate pathways, enhanced release of lactate. These findings indicate Glutamine-addiction in IDH-mutant-gliomas, pointing towards potential therapeutics targeted at glutamine metabolism for management of IDH-mutant-gliomas.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords